PTOMMSISG (54.98)
`Approved for uae through 14/90/2001. ORS 0884-0095
`U.S, Patent and Trademark Gfice, U.S. DEPARTMENT GF COMMERCE
`ieeeitsShyBopanenkHaduntonAg QP H8OS asQQANUTE BN FeRuOOYSa sauene6 8 codentinn of infnnnation unions i cieolsyes vald CNGcorer sunt
`
`SENSSAAARERRRATANASSASSINSAARARRAS
`[-“
`POWER OF ATTORNEY TO PROSECUTE APPLICATIONS BEFORE THE USPTO
`RAEN
`
`Sas
`NCARNNNRENANNNSARNAS
`
`¢ HOPaDYPavOReBiDIRVIOUSSewersofafomeygiveninheApoicatonmentied|ASARRAAANSARIAA
`;
`;
`3 GFR 3.73¢h}.
`. hereby gopaint
`
`Practitioners ssacolatad with the Customer Number:
`of
`
`128284
`
`oy
`E
`|. Practiionar(s: named below (if more than fen setent practitioners are is be neried, than & customer number must be Used
`hawwct
` SSSASASSSSSAVEY
`SEEMEEEEr
`
`Registration
`Narne
`Ragisiration
`
`Number
`SoeeS
`LORARAAE,
`
`
`
`
`Ro
`
`Mame
`
`et
`[|
`
`ARAMDREEDrDnaenpDoEbette.
`
`
`
`
`
`
`
`
`
`
`SSSAnnaaeeatne NNN A
`
`7 as attorneyis) or agent(s} io represent the undersigned before the United Stelss Patent and Trademark Office MSPTSS in conmention wih
`Sany and al patent aren assigned only to the undersigned scearding io ihe USPTO assignment meards or assignment decumsnis
`SENNANANSENANANNANENANAENANINNANNND
`5isitached te this form in accordance sRa7 CFR S.73{s).
`
`Figsee change the correspondence address far ihe application identified in ike stischedstatement under O7 GPR 2.73{b} te:
` x)The address aseacisiead with Customer Number:
`Aecrorenceib
`
`
`
`
`SocataaacntNnnieiawmanecnnd
`OR
`%
`BanaAAAAAAAAAAAAHinsenateetreeenemaennaannannapaganASEETRRSPERBYSSSSINAN :
`Biri or
`:
`SASAAAAE AAA
`individual Meme i
`AGGESS
`
` SASSER
`
`~
`
`FFFIEEenneM reninSUAINNSAANSRANRANARNDANYSANYSNNNSNNUVAVNSUNSNUVANUNAANSAAN
`Stats
`izip
`Gity
`RARwannnahwrnORNSYEE TER
`: Coualy
`‘Tataphone
`AERATION
`Asgignes Nene and Addrags:
`
`
`
`BASF Mant Science GmbH
`870868 Ludwigshafen
`Germany
`
`aaa
`
`
`RRA
`cosy of Gis form, together with « StatementGnaerSFCER 3.730) (rom PTOMSBSSor equivalentfs saquirad te be
`i fled in sack application in whisk this fomn is used. Ths sintsment under OP SFR 3,FHS) may bs completed ey ane of
`lite srsctilianans saseinted in dis domif ihe eepuitad sreaifieneris auiforizad ts ast on behalf of the sasignas,
`and must identlily the appiiestionin whteh this Powerof Atomey fs te be Sled,
`
`-_ SIGNATURE ofAasign
`
`
`The Idisidoslations Siensueand tide isSeekafSeSawis authorized to. acton behalfofthe assignes
`IatoAADACRNR
`
`a 25 APR. GUNG
`SH nSturS
`
`
`Name WSSHAANTPRRaccccceeaaacsatemnninsisissinananannnnnnnnn&STS
`
`
`S
`Fille
`ogreeast Sere
`.
`Nemas ~ SokASS
`os
`aS RSs
`
`SARESSN Atos
`
`saAARRRRNAALLANRNREENORRRNNR exNNRNANIAANA
`& So
`SS
`Sorad
`.
`FI’ SSSASV eg dea
`Wee SyaainVTS
`
`SseemanannnnsnSpnaanaRASRSOYBEE
`
`1 of 1119
`1 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Docket No.: 074017-0013-01-US
`(PATENT)
`
`In re Patent Application of:
`Petra CIRPUSetal.
`
`Application No.: Not Yet Assigned
`
`Confirmation No.: N/A
`
`Filed: Concurrently Herewith
`
`Art Unit: N/A
`
`For: METHOD FOR PRODUCING
`POLYUNSATURATED FATTY ACIDS
`
`Examiner: Not Yet Assigned
`
`INFORMATION DISCLOSURE STATEMENT (IDS)
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`Dear Sir:
`
`Pursuant to 37 CFR 1.56, 1.97 and 1.98, the attention of the Patent and Trademark Office
`
`is hereby directed to the referenceslisted on the attached PTO/SB/08. It is respectfully requested
`
`that the information be expressly considered during the prosecution of this application, and that
`
`the references be madeof record therein and appear amongthe “References Cited” on any patent
`
`to issue therefrom.
`
`This Information Disclosure Statement accompanies the new continuation patent
`
`application submitted herewith and correspondsto the Information Disclosure Statements
`
`previously submitted or cited in parent Application Serial No. 12/280,090.
`
`Copies of the references on the PTO/SB/08are not provided herewith pursuant to 37 CFR
`
`§ 1.98(d), because the references have been previously cited or submitted in parent Application
`
`Serial No. 12/280,090.
`
`In accordance with 37 CFR 1.97(g), the filing of this Information Disclosure Statement
`
`shall not be construed to mean that a search has been madeorthat no other material information
`
`as defined in 37 CFR 1.56(a) exists. In accordance with 37 CFR 1.97(h), the filing ofthis
`
`Information Disclosure statement shall not be construed to be an admission that any patent,
`
`2 of 1119
`2 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Application No.: Not Yet Assigned
`
`Docket No.: 074017-0013-01-US
`
`publication or other information referred to therein is “prior art” for this invention unless
`
`specifically designated as such. Moreover, Applicant understands that the Examiner will make
`
`an independent evaluation of the cited documents.
`
`It is submitted that the Information Disclosure Statementis in compliance with 37 CFR
`
`1.98 and the Examineris respectfully requested to consider the listed references.
`
`Applicant believes no fee is due with this submission. However,if a fee is due, the
`
`Director is hereby authorized to charge our Deposit Account No. 50-0573, under Order No.
`
`074017-0013-01-US, from which the undersigned is authorized to draw.
`
`Respectfully submitted,
`
`By__/ Hui-JuWa_/
`Hui-Ju Wu, Ph.D.
`Registration No.: 57,209
`Drinker Biddle & Reath LLP
`222 Delaware Ave., Ste. 1410
`Wilmington, Delaware 19801-1621
`(302) 467-4260
`(302) 351-6938 (Fax)
`Attorney for Applicant
`
`#85,080,132
`
`2
`
`3 of 1119
`3 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`PTO/AIA/15 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995 no personsare required to respondto a collection of information unlessit displays a valid OMB control number
`
`UTILITY
`PATENT APPLICATION
`TRANSMITTAL
`
`METHOD FOR PRODUCING POLYUNSATURATED
`FATTY ACIDS
`
`(Only for new nonprovisional applications under 37 CFR 1.53(b))
`APPLICATION ELEMENTS
`See MPEPchapter 600 concerning utility patent application contents.
`
`Express Mail Label No. PO
`ADDRESS TO:
`comoBox 1450
`Alexandria, VA 22313-1450
`
`Fee Transmittal Form
`(PTO/SB/17 or equivalent)
`Applicant asserts smallentity status.
`See 37 CFR 1.27
`Applicantcertifies micro entity status. See 37 CFR 1.29.
`Applicant must attach form PTO/SB/15AorB or equivalent.
`
`ACCOMPANYING APPLICATION PAPERS
`[| Assignment Papers
`(cover sheet & documenit(s))
`
`‘
`
`Nameof Assignee
`
`Powerof Attorney
`cotheseaumeen
`English Translation Document(if applicable)
`
`—
`
`xX
`
`
`
`_[_] Return Receipt Posteard
`(MPEP§ 503) (Should be specifically itemized)
`
`57,209
`
`90
`[Total Pages
`Specification
`Both the claims and abstract must start on a new page.
`(See MPEP § 608.01 (a) for information on the preferred arrangement)
`. [ Drawing(s) (35 U.S.C. 113)
`[Total Sheets
`4
`. Inventor's Oath or Declaration
`[Total Pages
`(including substitute statements under 37 CFR 1.64 and assignments
`serving as an oath or declaration under 37 CFR 1.63(e))
`
`
`
`.
`
`:
`
`
`
`.
`
`
`
`Information Disclosure Statement
`a
`.
`(PTO/SB/08 or PTO-1449)
`Newly executed (original or copy)
`:
`[ Copiesofcitations attached
`b. [x] A copy from a prior application (37 CFR 1.63(d))
`
`X|Application Data Sheet * See note below. . Preliminary Amendment
`
`See 37 GFR 1.76 (PTO/AIA/14 or equivalent)
`CD-ROM or CD-R
`in duplicate, large table, or Computer Program (Appendix)
`[| Landscape Table on CD
`
`Nucleotide and/or Amino Acid Sequence Submission ;r| Certified Copyof Priority Document(s)
`(if applicable, items a. — c. are required)
`L_ (if foreignpriority is claimed)
`Nonpublication Request
`a. [| Computer Readable Form (CRF)
`“L__] Under35 U.S.C. 122(b)(2)(B)(i). Applicant must attach form PTO/SB/35
`b.
`Specification SequenceListing on:
`or equivalent.
`i. [| CD-ROMor CD-R(2 copies); or
`Text File of Sequence Listing Submitted via EFS
`'
`Web
`ii. [| Paper
`c. [| Statements verifying identity of above copies
`*Note:
`(1) Benefit claims under 37 CFR 1.78 and foreign priority claims under 1.55 must be included in an Application Data Sheet (ADS).
`(2) For applicationsfiled under 35 U.S.C. 111, the application must contain an ADS specifying the applicant if the applicant is an
`assignee, person to whom theinventor is under an obligation to assign, or person who otherwise showssufficient proprietary
`interest in the matter. See 37 CFR 1.46(b).
`
`19. CORRESPONDENCE ADDRESS
`
`{x|The address associated with Customer Number: 123223 OR |_| Correspondence address below
`
`
`re
`wef
`Poy[SdSe]—~*d owe]SC
`Poourey|__| taenone|nt
`/Hui-Ju Wu/ [cae|~_September6, 2016
`
`:
`Hui-Ju Wu, Ph.D.
`
`Registration
`
`No.
`
`N
`
`#85,078,564
`
`4 of 1119
`4 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`{ P
`
`etra
`
`CIRPUS
`
`Mannheim
`
`Germany
`
`Application Data Sheet
`
`Inventor Information
`
`Inventor Number::
`
`Given Name::
`
`Family Name::
`
`City of Residence::
`
`Country of Residence::
`
`Street of mailing address::
`
`Landteilstr. 12
`
`Mannheim
`
`Germany
`
`68163
`
`2 J
`
`org
`
`BAUER
`
`Limburgerhof
`
`Germany
`
`Maxburgsir. 6
`
`Limburgerhof
`
`Germany
`
`67117
`
`Xiao
`
`Page # 1
`
`5 of 1119
`5 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`City of mailing address::
`
`Country of mailing address::
`
`Postal or Zip Code of mailing address::
`
`Inventor Number::
`
`Given Name::
`
`Family Name::
`
`City of Residence::
`
`Country of Residence::
`
`Street of mailing address::
`
`City of mailing address::
`
`Country of mailing address::
`
`Postal or Zip Code of mailing address::
`
`Inventor Number::
`
`Given Name::
`
`#85,078,563
`
`

`

`Family Name::
`
`City of Residence::
`
`State or Province of Residence::
`
`Country of Residence::
`
`QIU
`
`Saskatoon
`
`SK
`
`Canada
`
`Street of mailing address::
`
`403 Kendardine Road
`
`City of mailing address::
`
`Saskatoon
`
`State or Province of mailing address::
`
`SK
`
`Canada
`
`S7N 385
`
`4 G
`
`uohai
`
`WU
`
`Saskatoon
`
`SK
`
`Canada
`
`Country of mailing address::
`
`Postal or Zip Code of mailing address::
`
`Inventor Number::
`
`Given Name::
`
`Family Name::
`
`City of Residence::
`
`State or Province of Residence::
`
`Country of Residence::
`
`Street of mailing address::
`
`2103 Kenderdine Road
`
`City of mailing address::
`
`Saskatoon
`
`State or Province of mailing address::
`
`SK
`
`Country of mailing address::
`
`Postal or Zip Code of mailing address::
`
`Inventor Number::
`
`Given Name::
`
`#85,078,563
`
`Canada
`
`S7N 385
`
`Bifang
`
`Page #2
`
`6 of 1119
`6 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Family Name::
`
`City of Residence::
`
`State or Province of Residence::
`
`Country of Residence::
`
`CHENG
`
`Saskatoon
`
`SK
`
`Canada
`
`Street of mailing address::
`
`PBI, 110 Gymnasium Road
`
`City of mailing address::
`
`Saskatoon
`
`State or Province of mailing address::
`
`SK
`
`Canada
`
`S7N OW9
`
`6 M
`
`artin
`
`TRUKSA
`
`Saskatoon
`
`SK
`
`Canada
`
`14439 47 Avenue N.W.
`
`Edmonton
`
`Canada
`
`T6H OBY
`
`Tom
`
`WETJEN
`
`Page #3
`
`7 of 1119
`7 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`Country of mailing address::
`
`Postal or Zip Code of mailing address::
`
`Inventor Number::
`
`Given Name::
`
`Family Name::
`
`City of Residence::
`
`State or Province of Residence::
`
`Country of Residence::
`
`Street of mailing address::
`
`City of mailing address::
`
`Country of mailing address::
`
`Postal or Zip Code of mailing address::
`
`Inventor Number::
`
`Given Name::
`
`Family Name::
`
`#85,078,563
`
`

`

`City of Residence::
`
`Country of Residence::
`
`Mannheim
`
`Germany
`
`Street of mailing address::
`
`Meerwiesenstrasse 21
`
`City of mailing address::
`
`Country of mailing address::
`
`Postal or Zip Code of mailing address::
`
`Mannheim
`
`Germany
`
`68163
`
`CorrespondenceInformation
`
`Correspondence Customer Number::
`
`123223
`
`Application Information
`
`Application Type::
`
`Subject Matter::
`
`CD-ROM or CD-R?::
`
`Regular
`
`Utility
`
`None
`
`Sequence submission?::
`
`Text File via EFS Web
`
`Computer Readable Form (CRF)?::
`
`See Text File via EFS Web
`
`Title::
`
`METHOD FOR PRODUCING
`
`POLYUNSATURATED FATTY
`
`ACIDS
`
`Attorney Docket Number::
`
`074017-0013-01-US
`
`Requestfor Early Publication?::
`
`Request for Non-Publication?::
`
`Small Entity?::
`
`Petition included?::
`
`Portions or all of the application associated with
`
`No
`
`No
`
`No
`
`No
`
`No
`
`#85,078,563
`
`Page # 4
`
`8 of 1119
`8 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`this Application Data Sheet mayfall under a
`
`Secrecy Order pursuant to 37 CFR 5.2::
`
`This application (1) claims priority to or the
`
`No
`
`benefit of an application filed before March 16,
`
`2013 and (2) also contains, or contained at any
`
`time, a claim to a claimed invention that has an
`
`effective filing date on or after March 16, 2013::
`
`Representative Information
`
`Representative Customer Number::
`
`123223
`
`Domestic Priority Information
`
`Application::
`
`Continuity Type::
`
`Parent Application::
`
`Parent Filing Date::
`
`This Application
`
`Continuation of
`
`12/280,090
`
`08/20/08
`
`
`
`National Stage of PCT/EP2007/051675|02/21/07
`
`Foreign Priority Information
`
`|Country:; Application number::
`
`Filing Date::
`
`Priority Claimed::
`
` 12/280,090
`09/07/06 pe
`EuropeanPatenta 06120309.7
`
`{ A
`
`ssignee
`
`BASF Plant Science GmbH
`
`Applicant Information
`
`Applicant Number::
`
`Applicant Type::
`
`Organization Name::
`
`Street of mailing address::
`
`Carl-Bosch-Str. 38
`
`#85,078,563
`
`Page #5
`
`9 of 1119
`9 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`City of mailing address::
`
`Country of mailing address::
`
`Ludwigshafen
`
`Germany
`
`Postal or Zip Code of mailing address::
`
`67056
`
`Authorization or Opt-Out of Authorization to Permit Access
`
`Whenthis Application Data Sheet is properly signed andfiled with the application, applicant has provided written
`authority to permit a participating foreign intellectual property (IP) office access to the instant application-as-filed
`(see paragraph A in subsection 1 below) and the European Patent Office (EPO) access to any search results from
`the instant application (see paragraph B in subsection 1 below).
`
`Should applicant choose notto provide an authorization identified in subsection 1 below, applicant must opt-outof
`the authorization by checking the corresponding box A or B or both in subsection 2 below.
`
`
`
`NOTE: This section of the Application Data Sheet is ONLY reviewed and processed with the INITIALfiling of an
`application. After the initial filing of an application, an Application Data Sheet cannot be used to provide or rescind
`authorization for access by a foreign IP office(s).
`Instead, Form PTO/SB/39 or PTO/SB/69 must be used as
`appropriate.
`
`1. Authorization to Permit Access bya Foreign Intellectual Property Office(s)
`
`A. Priority Document Exchange (PDX)- Unless box A in subsection 2 (opt-out of authorization) is checked, the
`undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO), the Japan Patent
`Office (JPO), the Korean Intellectual Property Office (KIPO), the State Intellectual Property Office of the People’s
`Republic of China (SIPO), the World Intellectual Property Organization (WIPO), and any other foreign intellectual
`propertyoffice participating with the USPTOin a bilateral or multilateral priority document exchange agreementin
`which a foreign application claiming priority to the instant patent application is filed, access to: (1) the instant patent
`application-as-filed and its related bibliographic data, (2) any foreign or domestic application to whichpriority or
`benefit is claimed by the instant application andits related bibliographic data, and (3) the date offiling of this
`Authorization. See 37 CFR 1.14(h)(1).
`
`B. Search Results from U.S. Application to EPO - Unless box B in subsection 2 (opt-out of authorization)is
`checked, the undersigned hereby grants the USPTOauthority to provide the EPO accessto the bibliographic
`data and search results from the instant patent application when a European patent application claiming priority to
`the instant patent application is filed. See 37 CFR 1.14(h)(2).
`
`The applicant is reminded that the EPO’s Rule 141(1) EPC (European Patent Convention) requires applicants to
`submit a copy of search results from the instant application without delay in a European patent application that
`claimspriority to the instant application.
`
`2. Opt-Out of Authorizations to Permit Access bya Foreign Intellectual Property Office(s)
`
`A. Applicant DOES NOTauthorize the USPTO to permit a participating foreign IP office access to the
`[| instant application-as-filed.
`If this box is checked, the USPTOwill not be providing a participating foreign IP
`office with any documents and information identified in subsection 1A above.
`
`B. Applicant DOES NOTauthorize the USPTOto transmit to the EPO any search results from the instant
`patent application.If this box is checked, the USPTOwill not be providing the EPO with search results from
`the instant application.
`NOTE: Oncethe application has published or is otherwise publicly available, the USPTO mayprovide accessto
`the application in accordance with 37 CFR 1.14.
`
`
`
`
`
`#85,078,563
`
`Page #6
`
`10 of 1119
`10 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Signature:
`NOTE: This Application Data Sheet must be signed in accordance with 37 CFR 1.33(b). However,if this
`Application
`
`Data Sheet is submitted with the INITIALfiling of the application and either box A or B is not checkedin
`subsection 2 of the “Authorization or Opt-Out of Authorization to Permit Access” section, then this form
`must
`also be signed in accordance with 37 CFR 1.14(c).
`This Application Data Sheet must be signed by a patent practitioner if one or more of the applicants is a
`juristic
`entity (e.g., corporation or association). If the applicant is two or morejoint inventors, this form must be signed by a
`patent practitioner, all joint inventors whoare the applicant, or one or morejoint inventor-applicants who have been
`given
`powerof attorney (e.g., see USPTO Form PTO/AIA/81) on behalf of all joint inventor-applicants.
`See 37 CFR 1.4(d) for the manner of making signatures and certifications.
`
`
`
`Signature|/Hui-Ju Wul 2016-09-06
`
`
`
`
`
`
`
`Name|Hui-Ju Wu, Ph.D. Registration Number|57,209
`
`#85,078,563
`
`Page #7
`
`11 of 1119
`11 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Declaration, Power ofAttorney and Petition
`
`Page 1 of 4
`DOGO0S7672
`
`We(1),the undersigned inventor(s), hereby declare(s) that:
`
`My residence, post office address and citizenship are as stated below next to my name,
`We (1) believe that we are {1 am) the original, first, and joint (sole) inventor(s) of the subject matter which is claimed
`and for which a patent is sought on the invention entitled
`
`the specification of which
`
`[ J is attached hereto,
`
`( ] was filed on
`
`Application Serial No.
`
`and amended on.
`
`as
`
`
`.
`
`[x] was filed as PCT intemational application
`
`Number _
`on
`
`and was amended under PCT Article 19
`
`on Gf applicable)
`
`We (D heseby state that we () have reviewed and understand the contents of the above-identified specification,
`including the claims, as amended by any amendment referred io above.
`We (1) acknowledgethe duty to disclose information known to be material to the patentability of this application
`as defined in Section 1.56 of Title 37 Code of Federal Regulations.
`
`We (1) hereby claim foreign priority benefits under 35 U.S.C, § 119(a) ~ (d) or § 365(b) of any foreign application(s)
`for patentor inventor's certificate, or § 365{a) of any PCT International Application which designated at least one country
`other than the United States, listed below and havealso identified below, by checking the box, any foreign application for
`patent or inventor's certificate, or PCT International Application having a tiling date before that of the application on
`which priority is claimed. Prior Foreign Application(®)
`
`
`
`Application No.
`
`Country
`
`Day/Month/Year
`
`Priority
`Claimed
`
`102006008030.0
`06120309.7
`
`Germany
`Europe
`
`21 February 2006
`OF September 2006
`
`[x] Yes
`[x] Yes
`
`[] No
`[] No
`
`pduspet.rdf
`
`12 of 1119
`12 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`We (} hereby claim the benefit under Tide 35, United States Codes, § 119fe) of any United States provisional
`application(s) listed below.
`
`(Application Number)
`
`(Application Number)
`
`(Filing Date)
`
`-
`' @iling Date)
`
`Page 2 of 4
`0000057672
`
`We (hereby claim the benefit under 35 U.S.C. § 120 of any United States application(s), or § 365(c) of any PCT
`International Application designating the United States, listed below and, insofar as the subject matter of each of the
`claims ofthis application is not disclosed in the prior United States or PCT International Application in the manner
`provided by the first paragraph of 35 U.S.C. § 112, I acknowledge the duty to disclose information which is material ico
`patentability as defined in 37CER § 1.56 which became available between the filing date of the prior application and the
`national or PCT Intemational filing date of this application.
`
`Application Serial No.
`
`Filing Date
`
`Status (pending, patented,
`abandoned)
`
`
`
`
`
`
`
`Thereby appoint the registered practitioner(s) associated with Customer No. 23416 to prosecute this application and to
`transact all business in the Patent and Trademark Office connected therewith. Direct all correspondence to Customer Number
`23416.
`We (1) declare thatall statements made herein of our (my) own knowledge are tme and that all statements made
`on information and belief are believed. to be tre; and further that these statements were made with the knowledge that willfni
`false statements and the like so made are punishable by fine or imprisonment, or both, under Section 1001 of
`Title 18 of the United States Code and that such willful false statements may jeopardize the validity of the application
`or any patent issuing thereon.
`
`
`
`
`
`
`pduspeLrd?
`
`13 of 1119
`13 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Petra Cirpus
`NAME GF SOLE OR FIRST INVENTOR
`
`Residence:
`
`Page 3 of 4
`0000057672
`
`Otto-Haha-St. 7
`67165 Waldsee
`Germany
`Citizen of Germany
`
`Post Office Address: same as residence
`
`
`Jérg Baer
`
`Residence:
`
`Maxbergstr.6
`67117 Limburgethot
`. Germany
`Citizen of Germany
`
`Post Office Address: same as residence
`
`Residence:
`
`403 Kendardine Road
`Saskatoon Sk. S7N 385
`Canada
`Citizen of Canada
`
`Past Office Address: same as residence
`
`Xiao Qiu
`NAME OF THIRD JOINT INVENTOR
`
` eeSignature of Inventor
`
`
`Residence:
`Guohai Wu
`
`NAME OF FOURTH JOINT INVENTOR
`
`
`
`Signature of inventor ~
`pae'y Hor), AI, LOO
`
`Bifang Cheng
`NAME OF FIFTH JOINT INVENTOR
`
`2103 Kendardine Road.
`Saskatoon Sk. S7IN 385
`Canada
`Citizen of Canada
`
`Post Office Address: same as residence
`
`
`Residence:
`PBI, £10 Gymnasium Road
`Saskatoon, Saskatchewan, S57 OW9
`Canada
`Citizen of Canada
`
`
`
`
`
`Post Office Address: same as residence
`
`
`
`pduspet.rdf
`
`14 of 1119
`14 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Martin Truksa
`NAME OF SIXTH JOINT INVENTOR
`
`i
`
`.{
`
`Page 4 of 4
`0000057672
`
`Residence:
`14339 47 Avenue N. W,
`Edmonton, 4B T6H OBS
`Canada
`Citizen of Canada
`PostOffice Address: same as residence
`
`“es
`
`ar fiwbam 7? “ ni ‘
`Signature of Inventor
`Dae% Apel 12, 200%
`
`Residence:
`‘tom Weljent’
`NAMEOFSEVENTH JOINT INVENTOR
`Meerwiesenstrasse 21
`
`
`ne
`68163 Mannheim
`Germany
`Citizen of Germany
`
`
`
`pduspetrdf
`
`15 of 1119
`15 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`PTO/SB/08b (07-09)
`Approved for use through 07/31/2016. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respondto a collection of information unlessit contains a valid OMB control number.
`
`Substitue for form 1449A/8/PTO
`
`INFORMATION DISCLOSURE
`STATEMENTBY APPLICANT
`
`(Use as many sheets as necessary)
`
`U.S. PATENT DOCUMENTS
`
`;
`
`Document Number
`
`Pages, Columns, Lines, Where
`
`
`
`Examiner|CiteNarainCoa(nawn)|MODY Nameof Patentee or Relevant Passagesor Relevant
`
`
`
`Initials* No.'|Number-Kind Code” (if|Number-KndCode(thrown) Applicant of Cited Document Figures Appear
`
`
`
`03-25-1997 |ThomasT.L. et al.
`|US-5,614,393
`AA*
`
`
`AB* 03-28-2000|Nishizawaet al.|US-6,043,411
`
`AC* 06-10-2004|Heinz et al.|US-2004/0111763
`
`
`AD* 04-26-2005|Browse et al.|US-6,884,921-B2
`
`AE*
`|US-6,459,018-B1
`10-01-2002 |Knutzon
`AF*
`|US-7,550,286-B2
`06-23-2009 |Damude etal.
`AG*
`|US-7,777,098-B2
`08-17-2010 |Cirpuset al.
`
`AH* |US-2004/0172682-A1|09-02-2004|Kinneyet al.
`
`Al* _|US-2004/0049805-A1|03-11-2004 |Lerchl et al.
`AJ*|US-2004/0053379-A1|03-18-2004 |Lerchl etal.
`AK*
`|US-2008/0155705-A1 {06-26-2008 |Zank etal.
`
`AL* |09-03-2009|Cirpus et al._|US-2009/0222951 -A1
`
`AM*
`|US-2010/0021976-A1 |01-28-2010 |Lerchl et al.
`
`
`
`
`
`FOREIGN PATENT DOCUMENTS
`
`
`
`Foreign Patent Document
`Publication
`Name of Patentee or
`Pages, Columns, Lines,
`3
`AL
`Dat
`:
`:
`Where
`Rel
`tt P
`E
`i
`Cit
`
`Iitials’| No|“KindCode’(known)|MM-DD-YYYY Applicant of Cited Document or RelevantFiguresAppear
`
`
`BA**|WO-91/13972 09-19-1991 |Calgene Inc.
`
`
`BB**|WO-93/06712 04-15-1993|Rhone-Poulenc Agrochimie
`BC** |WO-93/1 1245
`06-10-1993
`DuPont De Nemours and
`
`05-26-1994
`
`
`
`
`
`
`
`Pioneer Hi-Bred International,
`Inc.
`E.|. duPont de Nemours And
`Company
`Monsanto Company & Michigan
`49.
`08-18-1994 State University
`|WO-94/18337
`BF**
`
`BG**|WO-96/21022 07-11-1996 |Rhone-Poulenc Agrochimie
`
`BH**|WO-97/21340 06-19-1997|Cargill, Inc.
`Carnegie Institution Of
`
`BI**|WO-97/30582 08-28-1997 |Washington & Monsanto Co.,
`Inc.
`
`
`
`07-07-1993
`
`BD** |EP-0 550 162
`
`BE** |WO-94/11516
`
`ee
`
`BK** |EP-0 794 250
`
`BJU**|WO-01/85968-A2_ |11-15-2001 |Bioriginal Food & Science Corp.
`
`
`
`
`
`
`
`09-10-1997 SoM S.A. & Ferrero
`
`Examiner
`Signature
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whetheror notcitation is in conformance with MPEP 609. Drawline through citation if not in conformance and not
`considered. Include copyof this form with next communication to applicant.
`* CITE NO.: Those application(s) which are marked with an single asterisk (*) next to
`the Cite No. are not supplied (under 37 CFR 1.98(a)(2)(iii)) because that application wasfiled after June 30, 2003 oris available in the IFW.
`' Applicant's unique
`citation designation number(optional).
`? See Kinds Codesof
`3 Enter Oftice that issued the document, by the two-letter code (WIPO Standard ST.3). “For
`USPTO Patent Documents at www.usste.qov or MPEP 901.04.
`Japanese patent documents,the indication of the year of the reign of the Emperor must precedethe serial numberof the patent document.
`“Kind of document by
`the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. ® Applicantiis to place a check mark hereif English language
`Translation is attached.
`
`#85,080,135
`
`16 of 1119
`16 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`PTO/SB/08b (07-09)
`Approved for use through 07/31/2016. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respondto a collection of information unlessit contains a valid OMB control number.
`
`Substitue for form 1449A/8/PTO
`
`INFORMATION DISCLOSURE
`STATEMENTBY APPLICANT
`
`(Use as many sheets as necessary)
`
`|WO-98/46776
`WO-98/46764
`|W0O-98/46763
`
`L**
`we
`BM
`BN**
`
`fon
`
`10-22-1998 |Calgene LLC
`99.
`Calgene LLC & Abbott
`10-22-1998 Laboratories
`Calgene LLC & Abbott
`10-22-1998
`Laboratories
`Calgene LLC & Abbott
`10-22-1998 Laboratories
`WO-98/46765
`BO
`
`
`BP** 06-03-1999|University of Bristol|W0O-99/27111
`
`BQ** 12-16-1999|Abbott Laboratories|WO-99/64616
`
`
`BR** 03-09-2000|Abbott Laboratories|WO-00/12720
`
`BS**
`_|WO-00/21557
`04-20-2000 |Merck & Co., Inc.
`See US
`ee
`:
`2004/0111763
`BT
`WO-01/59128
`08-16-2001
`|BASF Aktiengesellschaft
`
`BU** 01-31-2002|Abbott Laboratories|WO-02/08401
`
`B
`
`BxX**
`
`|CA-2 485 060
`
`11-13-2003 |BASF Plant Science GmbH
`
`we
`
`BZ
`BA1**
`
`WO-2004/071467
`|WO-02/057464-A2
`
`|. duPont de Nemours and
`E.
`on.
`08-26-2004 Company
`07-25-2002 |BASF Plant Science GmbH
`
`
`
`
`
`BG1** |DE-101 02 337-A1
`
`07-25-2002 |BASF Plant Science GmbH
`
`See
`US2004/0049805
`BB1** 08-07-2003|Abbott Laboratories|WO-03/064596-A2
`
`
`BC1** |WO-95/18222-A1
`07-06-1995 |Kirin Beer Kabushiki Kaisha
`See US 6,043,411
`we
`7
`7
`94.
`Martek Biosciences Boulder
`|WO-02/092540-A1
`11-21-2002 Corporation
`BD1**
`
`BE1**|WO-02/081668-A2 10-17-2002|Abbott Laboratories
`See US
`
`BF1** |09-09-2005|BASF Plant Science GmbH|WO-2005/083093-A2 2008/0155705 &
`US 2009/0222951
`See US
`2004/0053379 &
`US 2010/0021976
`See Abstract
`
`
`
`
`
`
`
`
`BH1** |WO-2005/012316-A2
`Bl1i**
`|CA-2559360-A1
`
`|02-10-2005 |BASF Plant Science GmbH
`09-09-2005 |BASF Plant Science GmbH
`Commonwealth Scientific
`BJ1** |WO-2005/103253-A1|11-03-2005|And Industrial Research
`Organisation
`
`
`
`Examiner
`Signature
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whetheror notcitation is in conformance with MPEP 609. Drawline through citation if not in conformance and not
`considered. Include copyof this form with next communication to applicant.
`* CITE NO.: Those application(s) which are marked with an single asterisk (*) next to
`the Cite No. are not supplied (under 37 CFR 1.98(a)(2)(iii)) because that application wasfiled after June 30, 2003 oris available in the IFW.
`' Applicant's unique
`citation designation number(optional).
`? See Kinds Codesof
`3 Enter Oftice that issued the document, by the two-letter code (WIPO Standard ST.3). “For
`USPTO Patent Documents at www.uspto.gov or MPEP 901.04.
`Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial numberof the patent document. 5Kind of document by
`the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. ® Applicant is to place a check mark hereif English language
`Translation is attached.
`
`#85,080,135
`
`17 of 1119
`17 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`PTO/SB/08b (07-09)
`Approved for use through 07/31/2016. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respondto a collection of information unlessit contains a valid OMB control number.
`
`Substitue for form 1449A/8/PTO
`
`INFORMATION DISCLOSURE
`STATEMENTBY APPLICANT
`
`(Use as many sheets as necessary)
`
`
`
`
`
`Examiner
`Initials
`
`NON PATENTLITERATURE DOCUMENTS
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item (book,
`magazine, journal, serial, symposium, catalog, etc.), date, page(s), volume-issue number(s), publisher, city and/or
`country where published.
`“Danio rerio Polyunsaturated Fatty Acid Elongase Protein’, GenBank Database Accession No.
`AAN77156, February 15, 2006.
`Cronan, J.E. et al., “Biosynthesis of Membrane Lipids”, in “E. coli und Salmonella”, Section B2,
`Neidhardt, F.C. et al. eds., ASM Press, Washington, DC, (1996), pp. 612-636.
`Gerhardt, B., “Fatty Acid Degradation in Plants", Prog. Lipid Res. 31:4 (1992), pp. 417-446.
`Wada,H. et al., "Enhancement of Chilling Tolerance of a Cyanobacterium by Genetic
`Manipulation of Fatty Acid Desaturation", Nature 347 (1990), pp. 200-203.
`Yu, R. et al., "Production of Eicosapentaenoic Acid by a Recombinant Marine Cyanobacterium,
`Synechococcussp.", Lipids, 35:10 (2000), pp. 1061-1064.
`Magnuson, K.et al., "Regulation of Fatty Acid Biosynthesis in Escherichia coll’, Microbiological
`Reviews, 57:3 (1993), pp. 522-542.
`Akimoto, M. et al., "Carbon Dioxide Fixation and Polyunsaturated Fatty Acid Production by the
`Red Alga Porphyridium Cruentum", Applied Biochemistry and Biotechnology 73 (1998), pp. 269-
`278.
`Stymne,S., "Biosynthesis of 'Uncommon' Fatty Acids and Their Incorporation into
`Triacylglycerols", Biochemistry and Molecular Biology of Membrane and Storage Lipids of
`Plants, N. Murata et al., Editors, The American Society of Plant Physiologists (1993), pp. 150-
`158.
`Frentzen, M., “Acyltransferases from Basic Science to Modified Seed Oils", Fett/Lipid, 100:4-5,
`S. (1998), pp. 161-166.
`Shanklin, J. et al., "Desaturation and Related Modifications of Fatty Acids", Annu. Rev. Plant
`Physiol. Plant Mol. Biol. 49 (1998), pp. 611-641.
`Drexler, H. et al., "Metabolic Engineering of Fatty Acids for Breeding of New Oilseed Crops:
`Strategies, Problems and First Results", J. Plant Physiol. 160 (2003), pp. 779-802.
`Domergue,F.et al., "Cloning and Functional Characterization of Phaeodactylum tricornutum
`Front-End Desaturases Involved in Eicosapentaenoic Acid Biosynthesis", Eur. J. Biochem. 269
`(2002), pp. 4105-4113.
`Totani, N. et al., "The Filamentous Fungus Mortierella alpina, High in Arachiodonic Acid", Lipids,
`22:2 (1987), pp. 1060-1062.
`Cleland, L.G. et al., "Fish Oil and Rheumatoid Arthritis: Antiinflammatory and Collateral Health
`Benefits", The Journal of Rheumatology, 27:10 (2000), pp. 2305-2307.
`Vazhappilly, R. et al., “Heterotrophic Production Potential of Omega-3 Polyunsaturated Fatty
`Acids by Microalgae and Algae-like Microorganisms", Botanica Marina 41 (1998), pp. 553-558.
`Tvr